Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company with a focus on Pain and CNS conditions, today announced that the Company presented a …
In a research report issued Friday, Brean Capital analyst Difei Yang downgraded shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) from Buy to Hold, after the pharma …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced financial results for the three and six months ended June 30, 2016. …
In a research report published Friday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), with …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced an initiative intended to optimize the Company’s resources and improve the effectiveness of …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced positive final results from a Phase IV Study assessing the effects of nighttime …
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is up 5% in pre-market trading after news that its drug Nuplazid received FDA approval on Friday after market …
Both biopharmaceutical companies Relypsa Inc (NASDAQ:RLYP) and Pernix Therapeutics Holdings Inc (NASDAQ:PTX) run into obstacles amidst preparing for the launch of their pipeline …
In a research report issued Friday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), while …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced financial results for the fourth quarter and year ended December 31, 2015. 2015 …
